MBXBF (Microbix Biosystems) Interest Expense : $-0.67 Mil (TTM As of Dec. 2024)

View and export this data going back to . Start your Free Trial

What is Microbix Biosystems Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Microbix Biosystems's interest expense for the three months ended in Dec. 2024 was $ -0.16 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2024 was $-0.67 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Microbix Biosystems's Operating Income for the three months ended in Dec. 2024 was $ 0.68 Mil. Microbix Biosystems's Interest Expense for the three months ended in Dec. 2024 was $ -0.16 Mil. Microbix Biosystems's Interest Coverage for the quarter that ended in Dec. 2024 was 4.20. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Microbix Biosystems Interest Expense Historical Data

The historical data trend for Microbix Biosystems's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Microbix Biosystems Interest Expense Chart

Microbix Biosystems Annual Data

Trend

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Sep24

Interest Expense

Get a 7-Day Free Trial

-0.80

-1.27

-0.62

-0.68

Microbix Biosystems Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Interest Expense	Get a 7-Day Free Trial															-0.17	-0.17	-0.17	-0.17	-0.16

Microbix Biosystems Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.67 Mil.

Microbix Biosystems (OTCPK:MBXBF) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Microbix Biosystems's Interest Expense for the three months ended in Dec. 2024 was $-0.16 Mil. Its Operating Income for the three months ended in Dec. 2024 was $0.68 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Dec. 2024 was $4.37 Mil.

Microbix Biosystems's Interest Coverage for the quarter that ended in Dec. 2024 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Dec. 2024 )	/	Interest Expense (Q: Dec. 2024 )
	=	-1	*	0.681	/	-0.162
	=	4.20

The higher the ratio, the stronger the company's financial strength is.

Microbix Biosystems Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Microbix Biosystems Inc (OTCPK:MBXBF) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

MBX:Canada

Address

265 Watline Avenue, Mississauga, ON, CAN, L4Z 1P3

Website

https://www.microbix.com

Microbix Biosystems Inc develops biological products and technologies. There are two operating segments: The development, manufacturing, and sale of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows and viral transport medium to enable collection of patient test samples and; Development and commercialization of novel and proprietary products or technologies such as Kinlytic. Geographically, it derives a majority of revenue from North America and also operates in Europe and other foreign countries.